Results

38,551 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Palonosetron (excl. Dafo. WKA), ATC A04AA05, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 411224-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. ILO), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410427-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a Non-Exclusive Discount Agreement under § 130a Abs. 8 SGB V for the Active Ingredient Fesoterodin, ATC Code G04BD11, for the Period from 01.08.2026 to 31.07.2028 (including Extension Option for 1x12 Months)

DAK-Gesundheit, HamburgTED 406821-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Calcipotriol (excluding Dafo. CRE), ATC D05AX02 for the period from 01.08.2026 to 31.07.2028 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 412848-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. PFT), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410634-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Varenicline, ATC N07BA03, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 410962-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clonazepam, ATC N03AE01 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 409047-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Dynamic Purchasing System for the procurement of consultancy, governance, development and maintenance services for information technologies, as well as corporate services for Correos Express

Consejo de Administración de Correos Express Paquetería Urgente, Coslada (Madrid)PLACSP 19918057

€30,096,0003 lots

Fri 22 Jun

967days

Notice of the establishment of a dynamic purchasing system (sda) pursuant to art. 32 of Legislative Decree 36/2023 for the supply of sanitary and hygiene products for the province of Brescia and the entities adhering to the CUC “area vasta Brescia”

Provincia di BresciaTED 437758-2026

€1,000,0001 lot, 3 years

Mon 25 Jun23:59 in Rome

970days

Dynamic Acquisition System for stationery, office supplies, and reprography

Gobierno Vasco - Gobernanza, Vitoria-GasteizTED 364466-2026

€1,635,9853 lots, 2 years

Sun 1 Jul12:00 in Madrid

976days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brivaracetam, ATC N03AX23 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496840-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Biperiden (excluding strength 4 mg), ATC N04AA02, for the period 01.09.26 – 31.08.28 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 495070-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Betamethasone + Clotrimazole, ATC D01AC20 for the period 01.09.2026 - 31.08.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 496714-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Cefixime (excluding Dafo. FTA), ATC J01DD08 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495268-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lidocaine, ATC N01BB02 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495164-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Perampanel, ATC N03AX22 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496953-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brinzolamide + Brimonidine, ATC S01EC24 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495328-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Perindopril arginine + Amlodipine + Indapamide, ATC C09BX01, for the period 01.9.26–31.8.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495404-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Capsaicin, ATC N01BX04, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496025-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Oxybutynin (excluding Dafo. PFT), ATC code G04BD04 for the period from 01.09.26 to 31.08.28 (including V.-option for 1x12 months)

DAK-Gesundheit, HamburgTED 494810-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.